Enter your login e-mail to the account
Search
- News in the treatment of lung cancer
doc. MUDr. Peter Beržinec, CSc.
(4/2012, Review articles ) - 13th Central European Lung Cancer Conference, Praha, 24. – 27. 6. 2012
doc. MUDr. Peter Beržinec, CSc.
(4/2012, Events ) - Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFRmutant lung cancers
doc. MUDr. Peter Beržinec, CSc.
(6/2013, Information & comments ) - How to improve the first line treatment of NSCLC with EGFR mutation?
doc. MUDr. Peter Beržinec, CSc.
(6/2016, Review articles ) - 14. svetová konferencia o karcinóme pľúc v Amsterdame
doc. MUDr. Peter Beržinec, CSc.
(5/2011, Events ) - Exon 20 insertions and other uncommon EGFR mutations in non-small cell lung cancer
MUDr. Gabriela Chowaniecová, PhD., prof. MUDr. Dalibor Ondruš, DrSc.
(4/2023, Review articles ) - Effectivity of reduced dose of afatinib in patient with metastatic del 19 adenocarcinoma
MUDr. Michal Urda, MUDr. Simona Laštíková, MUDr. Juraj Mazal
(3/2020, Case reports ) - Lung cancer molecular testing in Slovak Republic – view clinical practise
doc. MUDr. Peter Beržinec, CSc., MUDr. Peter Kasan, MUDr. Andrea Cipková, MPH., MUDr. Mária Černá, CSc., MUDr. Róbert Godál, MUDr. Gabriela Chowaniecová, MUDr. Igor Andrašina, CSc.
(6/2015, Main topic ) - Skin toxicity of EGFR inhibitors
MUDr. Katarína Poláková, PhD.
(6/2016, Review articles ) - Správa z podujatia ASCO Chicago 2012
(3/2012, Events ) - Non small-cell lung cancer and treatment options after tyrosine kinase inhibitors failure in the first line
MUDr. Gabriela Chowaniecová
(5/2014, Original articles & case reports ) - ESMO 2010 – kongres, ktorý prelomil rekordy
doc. MUDr. Peter Beržinec, CSc.
(6/2010, Events ) - Správa z Best of ASCO® Slovakia 2012
MUDr. Mária Rečková
(6/2012, Events )
- Nové liečivá v EÚ registrované v roku 2013 (I.)
PharmDr. Peter Stanko
(4/2013, New drugs )